Disease activity drives transcriptomic heterogeneity in early untreated rheumatoid synovitis.

Publication Year: 2023

DOI:
10.1136/ard-2023-224068

PMCID:
PMC10646909

PMID:
37507201

Journal Information

Full Title: Ann Rheum Dis

Abbreviation: Ann Rheum Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Rheumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"sequencing data were deposited in the gene expression omnibus of the national centre for biotechnology information and are accessible through gene expression omnibus accession number gse225731.; sequencing data and metadata were deposited in the gene expression omnibus of the national center for biotechnology information ( https://www ncbi nlm nih gov/geo/ ) and are freely accessible for public use through gene expression omnibus accession number gse225731."

Code Sharing
Evidence found in paper:

"Competing interests: BL is currently employed at UCB Pharma, Anderlecht, Belgium."

Evidence found in paper:

"Funding: This work was funded in part by unrestricted grants from Cap48 (RTBF), Fonds de la Recherche Scientifique (FNRS) under Grant no. CDR J.0124.22, Actions de Recherché Concertées, UCLouvain (A.R.C. grant 19/24-098), and Fonds de la Recherche Fondamentale Stratégique-WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Belgium (Grant WELBIO-CR-2019A-03R). CT was funded by the FNRS and Fondation Saint-Luc (Cliniques Universitaires Saint-Luc). NL is a chercheur qualifiée of the FNRS."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025